Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Insights and Analysis
27 February 2024
This article aims to introduce three recent regulatory updates in China’s life science sector. These updates involve incentives for locally-manufacturing approved foreign drugs,...
Insights and Analysis
26 January 2024
On 29 December 2023, China’s top legislature, the Standing Committee of the National People’s Congress, adopted the amended Company Law of the People’s Republic of China,...
News
15 December 2023
Life sciences companies engaged in early development programs face a number of strategic considerations, such as where and how to administer the early stage scientific studies and each...
Insights and Analysis
27 November 2023
Assessing for years, and after circulating a draft for public comments in 2022, the Ministry of Industry and Information Technology, Ministry of Public Security, Ministry of Housing and...
News
07 November 2023
Today, the 1961 Hague Apostille Convention enters into force in China. The Convention aims to abolish the requirement of legalization of foreign official documents, replacing it with the...
Insights and Analysis
13 June 2023
Our seventh publication of Getting the Deal Through: Automotive and Mobility looks at the once in a century transition of the automotive and mobility industry oriented around a change...
Insights and Analysis
08 June 2023
For the purpose of providing further detailed guidance on the implementation of the Human Genetic Resources Administration Rules released in May 2019, after years of waiting, China’s...
News
24 May 2023
As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan ...
Insights and Analysis
18 May 2023
On March 31, 2023, the Center for Drug Evaluation under the PRC National Medical Products Administration issued the Work Specification for Accelerating the Review of Innovative Drug...
